Boston Scientific(US:BSX) ZACKSยท2024-10-02 23:20Company Performance - Boston Scientific (BSX) closed at $84.49, with a +0.42% change from the previous day's closing price, outperforming the S&P 500 which gained 0.01% [1] - Over the last month, Boston Scientific's shares increased by 3.7%, while the Medical sector experienced a loss of 3.6% and the S&P 500 gained 1.21% [1] - The company is expected to report an EPS of $0.58, reflecting a 16% increase from the same quarter last year, with a projected quarterly revenue of $4.03 billion, up 14.36% year-over-year [1] Full Year Estimates - For the full year, earnings are projected at $2.40 per share and revenue at $16.26 billion, indicating increases of +17.07% and +14.22% respectively from the previous year [2] Analyst Sentiment - Recent changes to analyst estimates for Boston Scientific indicate positive sentiment, suggesting optimism regarding the company's business and profitability [2] - The Zacks Rank system currently rates Boston Scientific at 2 (Buy), with a historical average annual return of +25% for 1 rated stocks since 1988 [3] Valuation Metrics - Boston Scientific has a Forward P/E ratio of 35.05, compared to the industry average of 24.52, indicating it is trading at a premium [3] - The company has a PEG ratio of 2.79, while the Medical - Products industry has an average PEG ratio of 2 [3] Industry Overview - The Medical - Products industry is part of the Medical sector and holds a Zacks Industry Rank of 50, placing it in the top 20% of over 250 industries [4] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [4]